Pilot Open-label Study of the Effect of Etanercept on Vascular Inflammation in Patients With Active Rheumatoid Arthritis
Phase of Trial: Phase IV
Latest Information Update: 09 Feb 2017
Price : $35 *
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 06 Feb 2017 Status changed from active, no longer recruiting to discontinued due to Recruitment difficulties.
- 15 Sep 2016 Planned End Date changed from 1 Dec 2018 to 1 Nov 2016.